ISAM 2019 – Workshop 1 Details

The Basics of Aerosol Technology for Respiratory Drug Delivery

Date: Saturday, May 25, 2019
Time: 9:00 - 17:00  *subject to change
Location: Level A4 • 2M2C (ISAM 2019 venue) 

Download the detailed program for this workshop as a PDF here:

Workshop 1 Detailed Program (updated April 1) Workshop 1 Detailed Program (updated April 1) (75 KB)


Sunalene Devadason, The University of Western Australia

Jim Fink, Aerogen Pharma Corporation and Sr. Fellow Clinical Aerosol Product Development for Dance Biopharm Inc.

Target Audience:
Providers of lung health, including clinicians, pediatricians, internists, nurses, pharmacists, respiratory therapists and asthma educators. Participants with clinical, administrative and teaching responsibilities to integrate program content into practice and resource support.

Should attendees have specific expertise to benefit from this session? No

Session Summary:
This course will focus on practical aspects of clinical aerosol medicine. Speakers will discuss aerosol devices, selection for different patient groups (e.g., pediatrics), device interchangeability, common use errors and why patients fail to adhere to prescribed therapy. Hands-on device demonstration and a practical session on how to teach correct use of inhaler devices will include strategies/resources available for teaching patients and healthcare workers. Special considerations and recent innovations in aerosol therapy will be explored.                             

At the conclusion of this session, the participant will be able to:

1. Describe basic physiology and factors that affect aerosol dose and delivery.
2. Define terms used to describe aerosol characteristics, generation and delivery.
3. Identify a broad range of aerosol devices and their principles of operation.
4. List methods of aerosol characterization and dose estimation.
5. Discuss device selection criteria for a variety of patient and clinical situations.

Statement of Clinical/Scientific Importance:
Worldwide, medical aerosols are prescribed for more than 80 million patients each year. Surveys report between 28 -68 % of patients do not use their inhalers sufficiently to benefit from their inhaled medications, correlating with 39 – 67% of physicians, nurses, pharmacists and allied health personnel unable to demonstrate critical performance steps for effective administration. This workshop is designed to narrow this professional practice gap by increasing knowledge of the devices and techniques of aerosol delivery and the evidence supporting differential selection for specific patient groups, from infants to adults, and patients in wealthy industrialized nations to the third world. Participants will gain competence with hands-on exposure to a broad range of nebulizers and inhalers. Methods and strategies for teaching health care workers, care providers and patients will be discussed. New devices and novel applications for aerosol medicine, such as inhaled vaccines will be presented. This workshop will enable a broad range of clinicians and educators to better enable their patients to more effectively self-administer and adhere to therapies crucial to management of their respiratory disease, improving both patient health and quality of life. This workshop will also be useful for scientists and researchers who are new to the aerosol research field, and who want to develop a better understanding of aerosol dosing and delivery characteristics.


Arzu Ari, Texas State University
Differential device selection and integration of device to patient – patient education and training

Anthony Hickey, University of North Carolina 

Kevin Stapleton, Allergan

Chris O’Callaghan, University College London

Sunalene Devadason, The University of Western Australia
Pediatric Considerations

Jim Fink, Aerogen Pharma Corporation and Sr. Fellow Clinical Aerosol Product Development for Dance Biopharm Inc.
Innovation is Aerosols in Medicine – From Smart Nebulizers to Critical Care to Vaccines

Full bios to be added shortly.